Skip to content

Hydrocortisone/Ciprofloxacin

    DEA Class; Rx

    Common Brand Names; Cipro HC Otic

    • Antibiotics/Corticosteroids, Otic

    Fluoroquinolone/corticosteroid combination otic suspension for acute otitis externa due to Proteus mirabilis, Pseudomonas aeruginosa, and Staphylococcus aureus.

    Indicated for the treatment of acute otitis externa due to susceptible organisms.

    Hypersensitivity to drugs or components

    Tympanic membrane perforation (nonsterile preparation)

    Viral infections of external canal including varicella & herpes simplex infections

    • Headache
    • Pruritus
    • Migraine headache
    • Hyperesthesia
    • Paresthesias
    • Fungal dermatitis
    • Cough
    • Rash
    • Dermatitis
    • Urticaria
    • Alopecia

    Not for ophthalmic use or injection

    Prolonged use may result in bacterial or fungal overgrowth

    Resistance to the product may develop

    If infection not improved after one week of therapy, cultures should be obtained to guide further treatment

    Discontinue at first appearance of skin rash or any other sign of hypersensitivity; serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following first dose, reported in patients receiving systemic quinolones; serious acute hypersensitivity reactions may require immediate emergency treatment

    Dropper cap contains natural rubber (latex) which may cause severe allergic reactions

    Pregnancy Category: C

    Lactation: Excretion in breast milk unknown; not recommended

    Adults

    6 drops/day to affected ear(s).

    Geriatric

    6 drops/day to affected ear(s).

    Adolescents

    6 drops/day to affected ear(s).

    Children

    6 drops/day to affected ear(s).

    Infants

    Safety and efficacy have not been established.

    Neonates

    Safety and efficacy have not been established.

    Ciprofloxacin hydrochloride/hydrocortisone

    suspension

    • 0.2%/1%